Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Goodwill & Intangibles (2015 - 2026)

Mesoblast's (MEOBF) quarterly Goodwill & Intangibles came in at $566.4 million in Q2 2026, down 0.95% year-over-year from $571.8 million in Q2 2025, and little changed quarter-over-quarter from $568.8 million in Q4 2025.

Analysis

Mesoblast (MEOBF) Goodwill & Intangibles (2015 - 2026) Analysis & Trends

Mesoblast has disclosed Goodwill & Intangibles across 12 years of filings, most recently posting $566.4 million for Q2 2026.

  • In Q2 2026, Goodwill & Intangibles fell 0.95% year-over-year to $566.4 million; the TTM figure through Jun 2026 stood at $566.4 million (down 0.95% YoY), while the FY2026 annual figure was $566.4 million, down 0.95% from the prior year.
  • Goodwill & Intangibles came in at $566.4 million for Q2 2026 at Mesoblast, roughly flat from $568.8 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $578.9 million in Q1 2022 to a low of $566.4 million in Q2 2026.
  • Average Goodwill & Intangibles over 5 years is $575.2 million, with a median of $576.9 million recorded in 2023.
  • Year-over-year, Goodwill & Intangibles decreased 0.23% in 2023 and slipped 1.06% in 2025.
  • Over 5 years, Goodwill & Intangibles stood at $577.9 million in 2022, then retreated by 0.23% to $576.6 million in 2023, then fell by 0.29% to $574.9 million in 2024, then dropped by 1.06% to $568.8 million in 2025, then slipped by 0.43% to $566.4 million in 2026.
  • Per Business Quant data, the three most recent Goodwill & Intangibles figures were $566.4 million in Q2 2026, $568.8 million in Q4 2025, and $571.8 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Mesoblast 246.02 Mn 143.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 566.37 Mn
Dec 31, 2025 568.80 Mn
Jun 30, 2025 571.83 Mn
Dec 31, 2024 574.88 Mn
Jun 30, 2024 575.74 Mn
Dec 31, 2023 576.56 Mn
Jun 30, 2023 577.18 Mn
Mar 31, 2023 577.53 Mn
Dec 31, 2022 577.90 Mn
Sep 30, 2022 578.28 Mn
Jun 30, 2022 578.65 Mn
Mar 31, 2022 578.95 Mn
Dec 31, 2021 579.84 Mn
Sep 30, 2021 580.18 Mn
Jun 30, 2021 580.55 Mn
Mar 31, 2021 580.94 Mn
Dec 31, 2020 581.33 Mn
Sep 30, 2020 581.22 Mn
Jun 30, 2020 581.60 Mn
Mar 31, 2020 581.94 Mn